Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01055
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2019
Authors
Publisher
Frontiers Media SA